ACE2 and COVID-19: To further improve the antiviral efficiency of EV vaccines, some researchers have designed palmitoylated ACE2 extracellular vesicles (PM‐ACE2‐EVs) for the prevention and treatment of new coronavirus disease (COVID‐19).194